AG200-15

DRUG5 trials

Sponsors

Agile Therapeutics

Conditions

ContraceptionHealthy

Phase 1

AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol

CompletedNCT01243580

Agile TherapeuticsHealthy

Start: 2009-08-31End: 2009-12-31Updated: 2018-01-23

Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers

CompletedNCT01375946

Agile TherapeuticsHealthy

Start: 2011-05-31End: 2011-06-30Updated: 2018-07-31

Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females

CompletedNCT01422135

Agile TherapeuticsHealthy

Start: 2011-02-28End: 2011-04-30Updated: 2018-12-31

Phase 3

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

CompletedNCT01236768

Agile TherapeuticsContraception

Start: 2010-10-31End: 2011-06-30Updated: 2017-09-15

Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

CompletedNCT02158572

Agile TherapeuticsHealthy

Start: 2014-08-31End: 2016-11-30Updated: 2020-05-06

Related Papers

Extended regimen of a levonorgestrel/ethinyl estradiol transdermal delivery system: Predicted serum hormone levels using a population pharmacokinetic model

PLoS ONE2022-12-274 citations

The Patch Wear Profile from SECURE: A Once-Weekly Low-Dose Contraceptive Patch Study [7F]

Obstetrics and Gynecology2018-04-271 citations

Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial.

2011-11-3018 citations